Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdanro, Dong-gu, Daegu 41062, Korea.
Nutrients. 2021 Oct 20;13(11):3690. doi: 10.3390/nu13113690.
Oxidative stress-mediated neuronal damage is associated with the pathogenesis and development of neurodegenerative diseases. has antioxidant properties. However, the neuroprotective effects and the cellular mechanism of ethanol extract (CIE) against oxidative damage in hippocampal neuronal cells have not been clearly elucidated. Therefore, this study investigated whether CIE has protective effects against hydrogen peroxide (HO)-induced oxidative toxicity in HT22 cells. CIE pretreatment significantly improved neuronal cell viability. Moreover, the formation of intracellular reactive oxygen species and apoptotic bodies, and mitochondrial depolarization were significantly reduced in HT22 cells with HO-induced oxidative toxicity. Furthermore, CIE increased the phosphorylation of tropomyosin-related kinase receptor B (TrkB), protein kinase B (Akt), cAMP response element-binding protein, the expression of brain-derived neurotrophic factor, antioxidant enzymes, and the nuclear translocation of nuclear factor erythroid 2-related factor 2 by activating the TrkB/Akt signaling pathway. In contrast, the addition of K252a, a TrkB inhibitor, or MK-2206, an Akt-selective inhibitor, reduced the neuroprotective and antioxidant effects of CIE. Taken together; CIE exhibits neuroprotective and antioxidant effects against oxidative damage. Therefore, it can be a potential agent for treating oxidative stress-related neurodegenerative diseases.
氧化应激介导的神经元损伤与神经退行性疾病的发病机制和发展有关。 具有抗氧化特性。然而, 乙醇提取物 (CIE) 对海马神经元细胞氧化损伤的神经保护作用及其细胞机制尚未阐明。因此,本研究探讨了 CIE 是否对 HT22 细胞中过氧化氢 (HO) 诱导的氧化毒性具有保护作用。CIE 预处理可显著提高神经元细胞活力。此外,在 HO 诱导的氧化毒性 HT22 细胞中,细胞内活性氧和凋亡小体的形成以及线粒体去极化明显减少。此外,CIE 通过激活 TrkB/Akt 信号通路增加原肌球蛋白相关激酶受体 B (TrkB)、蛋白激酶 B (Akt)、cAMP 反应元件结合蛋白、脑源性神经营养因子的表达、抗氧化酶和核红细胞 2 相关因子 2 的核易位。相反,添加 TrkB 抑制剂 K252a 或 Akt 选择性抑制剂 MK-2206 会降低 CIE 的神经保护和抗氧化作用。总之,CIE 对氧化损伤表现出神经保护和抗氧化作用。因此,它可能是治疗与氧化应激相关的神经退行性疾病的潜在药物。